Skip to content
← Back to this collection

PUBLICATIONS · 38899716

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2024 Nov 7
First author
Long GV

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Long GV
      type
      Author
    2. name
      Hauschild A
      type
      Author
    3. name
      Santinami M
      type
      Author
    4. name
      Kirkwood JM
      type
      Author
    5. name
      Atkinson V
      type
      Author
    6. name
      Mandala M
      type
      Author
    7. name
      Merelli B
      type
      Author
    8. name
      Sileni VC
      type
      Author
    9. name
      Nyakas M
      type
      Author
    10. name
      Haydon A
      type
      Author
    11. name
      Dutriaux C
      type
      Author
    12. name
      Robert C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Long GV
      type
      Author
    2. name
      Hauschild A
      type
      Author
    3. name
      Santinami M
      type
      Author
    4. name
      Kirkwood JM
      type
      Author
    5. name
      Atkinson V
      type
      Author
    6. name
      Mandala M
      type
      Author
    7. name
      Merelli B
      type
      Author
    8. name
      Sileni VC
      type
      Author
    9. name
      Nyakas M
      type
      Author
    10. name
      Haydon A
      type
      Author
    11. name
      Dutriaux C
      type
      Author
    12. name
      Robert C
      type
      Author
    bibliography ids
    1. nci-bib-2af310b6aba87aeec8bd5ec2
    book metadata
    content sha256
    44af3bc4da68ffd24965b296cbf5086ec1ec1f840a169fe92ace29ea26e5ab4e
    document type
    citation
    dois
    1. 10.1056/NEJMoa2404139
    electronic publication date
    display
    2024 Jun 19
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38899716
    immutable id
    pubmed:38899716@44af3bc4da68ffd24965b296cbf5086ec1ec1f840a169fe92ace29ea26e5ab4e
    journal
    abbreviation
    N Engl J Med
    issn electronic
    1533-4406
    issn print
    0028-4793
    issue
    18
    name
    The New England journal of medicine
    nlm unique id
    0255562
    pages
    1709-1720
    volume
    391
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38899716
      provenance
      batch id
      3e43afde6f26fc8df6da
      provider
      NCBI PubMed ESummary
      record sha256
      0b2b6718901bb2beb8860866f444fa7dbdb9a3530b26379f95e706c20dafc044
      response sha256
      fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
      retrieved at
      2026-09-09T23:48:21.145285+00:00
      publication date
      display
      2024 Nov 7
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Multicenter Study
      4. Clinical Trial, Phase III
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38899716/
      title
      Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.

      Preserved source evidence · Not medical advice